Antarka develops Antarctic-derived enzymes that repair UV-damaged skin DNA, powering next-generation anti-aging and skin health solutions.
Antarka Bio has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in February 2026.
Antarka Bio's investors include GS Futures, SOSV, SOSV SF & NY (Fka IndieBio), Zentynel Frontier Investments, Natura Ventures.
Antarka Bio is headquartered in Montevideo, Uruguay.
Antarka develops Antarctic-derived enzymes that repair UV-damaged skin DNA, powering next-generation anti-aging and skin health solutions.
Antarka Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Antarka Bio — Funding & Investors." VCBacked, February 9, 2026, https://www.vcbacked.co/company/antarka-bio. Accessed November 14, 2026.
VCBacked. (2026). Antarka Bio — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/antarka-bio
{{cite web |title=Antarka Bio — Funding & Investors |url=https://www.vcbacked.co/company/antarka-bio |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Antarka Bio? Request a listing update